LIXTE Biotechnology (LIXT) announced the closing of its previously announced registered direct offering priced at-the-market ...

Brent Sabatini, the Senior Vice President and Chief Accounting Officer at Vir Biotechnology, Inc. (NASDAQ:VIR), recently sold 1,562 shares of the company's common stock. According to InvestingPro data ...

I will start by saying that biotechnology is a game Changer, it has revolutionised various fields, including medicare, agricultural business, industrial engineering and environmental science, ...

Project Vital is a statewide initiative to invest in research, workforce development, and biotech startups, positioning Virginia as a leader in biotechnology. Virginia Tech, Carilion Clinic, and the ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One ...

Wilmington Savings Fund Society FSB trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 34.4% in ...

The aggregate gross proceeds to the Company from the offering were approximately $1,050,000, before deducting the placement ...

Prime Minister Narendra Modi met Indian-American entrepreneur Vivek Ramaswamy in Washington to discuss India-US relations, ...